A Danish register-based study reveals flu vaccination reduces heart attack and stroke risk by curbing inflammation, offering a key strategy for aging populations and preventive health. Recent data sho...
Recent research reveals APOE4 increases hippocampal neuron excitability before Alzheimer’s symptoms, offering early detection via interictal spikes and potential interventions targeting Nell2 pr...
uPAR-targeted CAR T cell therapy shows promising results in solid tumors, with recent clinical trials and FDA designations advancing cancer immunotherapy towards precision medicine. Recent advancement...
Recent research shows lipid nanoparticles delivering mRNA can reduce tau protein aggregates in Alzheimer’s models, with Moderna advancing clinical trials and regulatory support accelerating deve...
A July 2024 study in ‘Nature Aging’ validates p-tau217 blood biomarkers for forecasting Alzheimer’s symptoms within 3-4 years, enhancing early intervention and personalized medicine....
Analytical post exploring CAR-T cell therapy’s potential to treat Alzheimer’s by targeting amyloid plaques, with insights from recent clinical trials and cost-benefit considerations. Innov...
A 2025 research paper finds that obese individuals with low choline levels face increased Alzheimer’s disease risk due to inflammation and neuronal damage, highlighting dietary interventions. Re...
The Phase 3 failure of semaglutide in Alzheimer’s disease highlights challenges in repurposing GLP-1 agonists, urging a shift towards biomarker-driven and personalized approaches in neurodegener...
